Running Point Capital Advisors, LLC Cortexyme, Inc. Transaction History

Running Point Capital Advisors, LLC

$256 Million
Q3 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 10, 2022	SELL	$11.35 - $97.17 $36,115 - $309,194	-3,182 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.0 - $120.21 $165,464 - $382,508	3,182 New	3,182 $292,000

Others Institutions Holding CRTX

# of Institutions

39

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

0

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.55 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

826K
Shares

$1.07 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

523K
Shares

$674,123
0.0% of portfolio
Almitas Capital LLC Santa Monica, CA

383K
Shares

$493,917
0.23% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Running Point Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Running Point Capital Advisors, LLC with notifications on news.